The Prognostic Role of Perineural Invasion for Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Jul 27

PMID 39061154

Authors

Zhuo-Ying Tao

Guang Chu

Yu-Xiong Su

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to conduct a comprehensive review of the predictive significance of PNI in HNSCC survival outcomes. A systematic search was conducted across multiple databases, and all studies published in the last decade were screened (Research Registry ID: reviewregistry1853). The included studies were assessed using the Quality in Prognosis Studies tool. Survival outcome data were extracted, combined, and presented as hazard ratios (HR) with a 95% confidence interval (CI). Totally, 74 studies encompassing 27,559 patients were analyzed and revealed a cumulative occurrent rate of 30% for PNI in HNSCC. PNI+ HNSCC patients had a worse overall survival (HR: 1.91, 95% CI: 1.71-2.13), disease-specific survival (HR: 1.79, 95% CI: 1.55-2.07), disease-free survival (HR: 1.82, 95% CI: 1.69-1.96), local recurrence (HR: 2.54, 95% CI: 1.93-3.33), locoregional recurrence (HR: 2.27, 95% CI: 1.82-2.82), locoregional relapse free survival (HR: 1.77, 95% CI: 1.28-2.45), distant metastasis (HR: 1.82, 95% CI: 1.34-2.48), and distant metastasis-free survival (HR: 2.97, 95% CI: 1.82-4.85) compared to those PNI- patients. The available evidence unequivocally establishes PNI as a critical prognostic factor for worse survival in HNSCC patients.

Citing Articles

The Oncological Outcome of Postoperative Radiotherapy in Patients with Node-Negative Early-Stage (T1/T2/N0) Oral Squamous Cell Carcinoma and Perineural Invasion: A Meta-Analysis.

Rao K, Sreeram M, de Bree R, Mendenhall W, Strojan P, Stenman G Cancers (Basel). 2025; 17(5).

PMID: 40075709 PMC: 11899070. DOI: 10.3390/cancers17050862.

Understanding the role of nerves in head and neck cancers - a review.

Rutkowski K, Gola M, Godlewski J, Starzynska A, Marvaso G, Mastroleo F Oncol Rev. 2025; 18:1514004.

PMID: 39906323 PMC: 11791411. DOI: 10.3389/or.2024.1514004.

References

BATSAKIS J . Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol. 1985; 94(4 Pt 1):426-7. View

Henson C, Abou-Foul A, Morton D, McDowell L, Baliga S, Bates J . Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer: a state of the art review and gap analysis. Front Oncol. 2023; 13:1263347. PMC: 10548228. DOI: 10.3389/fonc.2023.1263347. View

Yang X, Tian X, Wu K, Liu W, Li S, Zhang Z . Prognostic impact of perineural invasion in early stage oral tongue squamous cell carcinoma: Results from a prospective randomized trial. Surg Oncol. 2018; 27(2):123-128. DOI: 10.1016/j.suronc.2018.02.005. View

Huang Q, Huang Y, Chen C, Zhang Y, Zhou J, Xie C . Prognostic impact of lymphovascular and perineural invasion in squamous cell carcinoma of the tongue. Sci Rep. 2023; 13(1):3828. PMC: 9992656. DOI: 10.1038/s41598-023-30939-8. View

Liu S, Xu W, Liu L, Zhu Y, Wu Y, Lu H . Prognostic factors and treatment considerations of submandibular gland carcinomas: A population-based study. Oral Dis. 2022; 29(8):3298-3305. DOI: 10.1111/odi.14313. View

Shibata M, Ishikawa A, Ishii J, Anzai E, Yagishita H, Izumo T . Stiffness as measured with strain elastography is a prognostic factor for pT1/T2 tongue squamous cell carcinoma with muscle-layer invasion. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022; 135(4):558-566. DOI: 10.1016/j.oooo.2022.11.001. View

Cracchiolo J, Xu B, Migliacci J, Katabi N, Pfister D, Lee N . Patterns of recurrence in oral tongue cancer with perineural invasion. Head Neck. 2018; 40(6):1287-1295. PMC: 5980694. DOI: 10.1002/hed.25110. View

Cho J, Lim B, Kim E, Ko Y, Oh D, Noh J . Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy. Ann Surg Oncol. 2016; 23(13):4368-4375. DOI: 10.1245/s10434-016-5353-6. View

I Ghanem A, Schymick M, Bachiri S, Mannari A, Sheqwara J, Burmeister C . The effect of treatment package time in head and neck cancer patients treated with adjuvant radiotherapy and concurrent systemic therapy. World J Otorhinolaryngol Head Neck Surg. 2019; 5(3):160-167. PMC: 6849356. DOI: 10.1016/j.wjorl.2018.09.005. View

10.

Alves A, Paula D, Lima L, Dantas T, Mota M, Sousa F . Is immunohistochemistry more sensitive than hematoxylin-eosin staining for identifying perineural or lymphovascular invasion in oral squamous cell carcinoma? A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2022; 27(3):e238-e247. PMC: 9054170. DOI: 10.4317/medoral.25114. View

11.

Nguyen E, Mckenzie J, Clarke R, Lou S, Singh T . The Indications for Elective Neck Dissection in T1N0M0 Oral Cavity Squamous Cell Carcinoma. J Oral Maxillofac Surg. 2021; 79(8):1779-1793. DOI: 10.1016/j.joms.2021.01.042. View

12.

Dermody S, McMichael B, Bellile E, Marchiano E, Chinn S . Lymph node level ratio as a predictor of survival in oral cavity squamous cell carcinoma. Oral Oncol. 2023; 146:106572. DOI: 10.1016/j.oraloncology.2023.106572. View

13.

Sekikawa S, Kawachi H, Ogane S, Saito H, Takano M, Nomura T . Which Factors Affect the Long-Term Survival of Patients With Oral Squamous Cell Carcinoma With Distant Metastasis?. J Oral Maxillofac Surg. 2019; 78(3):469-478. DOI: 10.1016/j.joms.2019.10.018. View

14.

Lydiatt W, Patel S, OSullivan B, Brandwein M, Ridge J, Migliacci J . Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017; 67(2):122-137. DOI: 10.3322/caac.21389. View

15.

Zanoni D, Valero C, McGill M, Montero P, Shah J, Wong R . Distant metastasis in oral squamous cell carcinoma: Does the neutrophil-to-lymphocyte ratio act as a surrogate of the host immune status?. Oral Oncol. 2021; 124:105641. PMC: 9377276. DOI: 10.1016/j.oraloncology.2021.105641. View

16.

Liebig C, Ayala G, Wilks J, Berger D, Albo D . Perineural invasion in cancer: a review of the literature. Cancer. 2009; 115(15):3379-91. DOI: 10.1002/cncr.24396. View

17.

Zanoni D, Montero P, Migliacci J, Shah J, Wong R, Ganly I . Survival outcomes after treatment of cancer of the oral cavity (1985-2015). Oral Oncol. 2019; 90:115-121. PMC: 6417804. DOI: 10.1016/j.oraloncology.2019.02.001. View

18.

Jang J, Kim M, Ryu G, Choi N, Ko Y, Jeong H . Prediction of Lymph Node Metastasis by Tumor Dimension Versus Tumor Biological Properties in Head and Neck Squamous Cell Carcinomas. Cancer Res Treat. 2015; 48(1):54-62. PMC: 4720059. DOI: 10.4143/crt.2014.332. View

19.

Bobdey S, Mair M, Nair S, Nair D, Balasubramaniam G, Chaturvedi P . A Nomogram based prognostic score that is superior to conventional TNM staging in predicting outcome of surgically treated T4 buccal mucosa cancer: Time to think beyond TNM. Oral Oncol. 2018; 81:10-15. DOI: 10.1016/j.oraloncology.2018.04.002. View

20.

Kim T, Cha I, Choi E, Kim H, Kim H, Kim S . Postoperative Concurrent Chemoradiotherapy Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques. Front Oncol. 2021; 11:619372. PMC: 7994509. DOI: 10.3389/fonc.2021.619372. View